Predictors of Clinical Course and Treatment Response in DBT Programmes

StatusRecruiting
PhaseNot applicable
Started

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Track this trial
View on ClinicalTrials.gov ↗
Trial flagged as At Risk
Primary completion moved at least 4 years later Dec 31, 2025 → Dec 31, 2029
See other at-risk trials from Oslo University Hospital

Record History

See every version on ClinicalTrials.gov ↗

  1. Primary and study completion pushed from Dec 31, 2025 to Dec 31, 2029 Show 4 more changesShow less
    • Eligibility criteria expanded, about 7 words
    • Secondary endpoints: details revised at 2 of 2 entries
    • Site details revised at 5 of 5 sites
    • Study description expanded, about 4 words
  2. Primary and study completion dates: Dec 31, 2023 to Dec 31, 2025
    • Site details revised at 1 of 5 sites
    v5
  3. Primary and study completion dates: Dec 31, 2022 to Dec 31, 2023v4
  4. Re-verified, no change to tracked fieldsv3
  5. Secondary endpoints: details revised at 2 of 2 entriesv2
  6. Study First Submitted
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The project is a collaboration between The National Centre for Suicide Research and Prevention (NSSF) and clinical units with Dialectical Behaviour Therapy (DBT) programmes. A methodological and technological platform has been established that enables clinicians to deliver high quality treatments over extended periods of time, to evaluate their own performance and productivity and to report it in a uniform and systematic way that will enable comparison across clinical settings and programmes. The collected data constitute the basis for conducting the clinical study with the overall aim to study predictors of the clinical course and treatment response in patients admitted to DBT programmes in Norway.
Trial Details
NCT Number NCT04318899
Lead Sponsor Oslo University Hospital
Collaborators: Vestre Viken Hospital Trust, St. Olavs Hospital, Sykehuset Ostfold, University of Oslo, Nordlandssykehuset HF
Conditions
(from sponsor)		 Self Harm, Borderline Personality Disorder
Related terms Borderline Personality Disorder, Self-Injurious Behavior
Enrollment 250 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov